A detailed history of Wellington Management Group LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 7,892,799 shares of PTCT stock, worth $310 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,892,799
Previous 8,208,606 3.85%
Holding current value
$310 Million
Previous $251 Million 16.65%
% of portfolio
0.05%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.39 - $37.66 $9.6 Million - $11.9 Million
-315,807 Reduced 3.85%
7,892,799 $293 Million
Q2 2024

Aug 13, 2024

SELL
$24.69 - $40.12 $17.1 Million - $27.8 Million
-692,959 Reduced 7.78%
8,208,606 $251 Million
Q1 2024

May 15, 2024

BUY
$24.15 - $31.95 $215 Million - $284 Million
8,901,565 New
8,901,565 $259 Million
Q4 2023

Feb 12, 2024

BUY
$18.07 - $29.37 $177 Million - $288 Million
9,816,603 New
9,816,603 $271 Million
Q3 2023

Nov 14, 2023

BUY
$22.41 - $41.99 $59.4 Million - $111 Million
2,649,824 Added 39.05%
9,436,188 $211 Million
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $8.54 Million - $12.5 Million
-211,327 Reduced 3.02%
6,786,364 $276 Million
Q1 2023

May 12, 2023

SELL
$38.16 - $48.86 $16.5 Million - $21.2 Million
-433,216 Reduced 5.83%
6,997,691 $339 Million
Q4 2022

Feb 13, 2023

SELL
$33.53 - $54.79 $2.02 Million - $3.3 Million
-60,155 Reduced 0.8%
7,430,907 $284 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $19.1 Million - $24.6 Million
457,557 Added 6.51%
7,491,062 $376 Million
Q2 2022

Aug 15, 2022

SELL
$25.6 - $45.23 $28.6 Million - $50.5 Million
-1,117,036 Reduced 13.71%
7,033,505 $282 Million
Q1 2022

May 16, 2022

SELL
$33.33 - $44.6 $150,184 - $200,967
-4,506 Reduced 0.06%
8,150,541 $304 Million
Q4 2021

Feb 11, 2022

SELL
$35.36 - $41.86 $21.6 Million - $25.6 Million
-611,780 Reduced 6.98%
8,155,047 $325 Million
Q3 2021

Nov 15, 2021

BUY
$37.01 - $44.74 $1.31 Million - $1.59 Million
35,435 Added 0.41%
8,766,827 $326 Million
Q2 2021

Aug 16, 2021

SELL
$37.95 - $49.37 $17.4 Million - $22.7 Million
-458,965 Reduced 4.99%
8,731,392 $369 Million
Q1 2021

May 17, 2021

SELL
$46.8 - $68.92 $6.95 Million - $10.2 Million
-148,522 Reduced 1.59%
9,190,357 $435 Million
Q4 2020

Feb 12, 2021

SELL
$47.96 - $67.64 $6.42 Million - $9.05 Million
-133,857 Reduced 1.41%
9,338,879 $570 Million
Q3 2020

Nov 16, 2020

BUY
$45.41 - $57.07 $65.8 Million - $82.7 Million
1,449,037 Added 18.06%
9,472,736 $443 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $76 Million - $98.2 Million
1,785,531 Added 28.62%
8,023,699 $407 Million
Q1 2020

May 14, 2020

BUY
$32.37 - $59.36 $172 Million - $315 Million
5,300,979 Added 565.63%
6,238,168 $278 Million
Q4 2019

Feb 11, 2020

BUY
$32.22 - $50.07 $30.2 Million - $46.9 Million
937,189 New
937,189 $45 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.